89bio Publishes Positive Results from Phase 2 ENTRIGUE Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) in Nature Medicine by Seini Moimoi | Jun 24, 2023 | Portfolio News
Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress by Seini Moimoi | Jun 17, 2023 | Portfolio News
Avenge Bio Receives FDA Orphan Drug Designation for AVB-001 for the Treatment of Mesothelioma by Seini Moimoi | Jun 15, 2023 | Portfolio News
Somatus Expands Multi-State Value-Based Kidney Care Partnership with Kidney Care Center by Seini Moimoi | Jun 8, 2023 | Portfolio News
Theseus Pharmaceuticals Reports Initial Dose Escalation Data from Ongoing Phase 1/2 Trial of THE-630 in Patients with Advanced GIST by Seini Moimoi | May 25, 2023 | Portfolio News
89bio Initiates Phase 3 ENTRUST Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG) by Seini Moimoi | May 23, 2023 | Portfolio News